5-87268254-G-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_002890.3(RASA1):​c.-198G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00821 in 796,836 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0070 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 29 hom. )

Consequence

RASA1
NM_002890.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.90

Publications

2 publications found
Variant links:
Genes affected
RASA1 (HGNC:9871): (RAS p21 protein activator 1) The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]
RASA1 Gene-Disease associations (from GenCC):
  • capillary malformation-arteriovenous malformation 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, G2P
  • capillary malformation-arteriovenous malformation syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Parkes Weber syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • telangiectasia, hereditary hemorrhagic, type 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 5-87268254-G-T is Benign according to our data. Variant chr5-87268254-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 354501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00696 (1060/152346) while in subpopulation NFE AF = 0.0117 (799/68024). AF 95% confidence interval is 0.0111. There are 4 homozygotes in GnomAd4. There are 476 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1060 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002890.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RASA1
NM_002890.3
MANE Select
c.-198G>T
5_prime_UTR
Exon 1 of 25NP_002881.1P20936-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RASA1
ENST00000274376.11
TSL:1 MANE Select
c.-198G>T
5_prime_UTR
Exon 1 of 25ENSP00000274376.6P20936-1
RASA1
ENST00000515800.6
TSL:1
n.-198G>T
non_coding_transcript_exon
Exon 1 of 26ENSP00000423395.2P20936-3
RASA1
ENST00000515800.6
TSL:1
n.-198G>T
5_prime_UTR
Exon 1 of 26ENSP00000423395.2P20936-3

Frequencies

GnomAD3 genomes
AF:
0.00696
AC:
1060
AN:
152228
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00181
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00896
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0134
GnomAD4 exome
AF:
0.00851
AC:
5483
AN:
644490
Hom.:
29
Cov.:
8
AF XY:
0.00855
AC XY:
2787
AN XY:
325910
show subpopulations
African (AFR)
AF:
0.00181
AC:
29
AN:
16004
American (AMR)
AF:
0.00727
AC:
123
AN:
16912
Ashkenazi Jewish (ASJ)
AF:
0.000683
AC:
10
AN:
14650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30820
South Asian (SAS)
AF:
0.000974
AC:
42
AN:
43106
European-Finnish (FIN)
AF:
0.00354
AC:
105
AN:
29634
Middle Eastern (MID)
AF:
0.00629
AC:
15
AN:
2386
European-Non Finnish (NFE)
AF:
0.0107
AC:
4891
AN:
458652
Other (OTH)
AF:
0.00829
AC:
268
AN:
32326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
311
623
934
1246
1557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00696
AC:
1060
AN:
152346
Hom.:
4
Cov.:
32
AF XY:
0.00639
AC XY:
476
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00180
AC:
75
AN:
41588
American (AMR)
AF:
0.00895
AC:
137
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
799
AN:
68024
Other (OTH)
AF:
0.0133
AC:
28
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
59
118
176
235
294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0103
Hom.:
0
Bravo
AF:
0.00764
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Capillary malformation-arteriovenous malformation 1 (1)
-
-
1
Parkes Weber syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.30
CADD
Benign
21
DANN
Benign
0.94
PhyloP100
2.9
PromoterAI
-0.14
Neutral
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149279711; hg19: chr5-86564071; API